Havana, Cuba

Gretchen Bergado Báez


Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Gretchen Bergado Báez: Pioneering Vaccine Adjuvants in Havana

Introduction

Gretchen Bergado Báez is a distinguished inventor based in Havana, Cuba, recognized for her contributions to immunology and vaccine development. With a total of two patents to her name, she is at the forefront of innovative research aimed at enhancing vaccine efficacy.

Latest Patents

Gretchen's latest invention focuses on the development of nano-particles containing synthetic variants of GM3 ganglioside as adjuvants in vaccines. This groundbreaking invention outlines methods for obtaining nano-particulated adjuvants made from various synthetic GM3 ganglioside variants. These adjuvants are designed to stimulate specific immune responses, either humoral or cellular, against accompanying antigens. The patent details the preparation of immunogenic vaccine compositions that include peptides, polypeptides, or proteins integrated with these nanoparticles, created through the dispersion of hydrophobic proteins from the outer membrane complex (OMC) in solutions containing fully synthetic variants of GM3 ganglioside.

Career Highlights

Gretchen currently works at the Centro de Inmunología Molecular, where her research continues to impact the field of vaccine development significantly. Her innovative approaches aim to enhance the body's immune response through the application of advanced scientific methodologies.

Collaborations

Gretchen collaborates closely with esteemed colleagues, including Luis Enrique Fernández Molina and Belinda Sánchez Ramírez. Together, they contribute to key advancements in immunology that seek to improve vaccine performance and overall public health.

Conclusion

Gretchen Bergado Báez exemplifies the spirit of innovation in the medical field, particularly in vaccine research. Her patented work on synthetic GM3 ganglioside adjuvants marks an important step towards developing more effective vaccines, underscoring her role as a leading inventor in the evolving landscape of immunology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…